Status: current, Defined. Date: 31-Jul 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2004561000168112 | Ilaris (canakinumab 150 mg) powder for injection [4 x 150 mg vials] (&) (inert substance) diluent [4 vials], 1 pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2004571000168118 | Ilaris (4 x 150 mg vials, 4 x inert diluent vials), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ilaris (canakinumab 150 mg) powder for injection [4 x 150 mg vials] (&) (inert substance) diluent [4 vials], 1 pack (containered trade product pack) | has container type | pack | true | Inferred relationship | Some | ||
| Ilaris (canakinumab 150 mg) powder for injection [4 x 150 mg vials] (&) (inert substance) diluent [4 vials], 1 pack (containered trade product pack) | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Ilaris (canakinumab 150 mg) powder for injection [4 x 150 mg vials] (&) (inert substance) diluent [4 vials], 1 pack (containered trade product pack) | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Ilaris (canakinumab 150 mg) powder for injection [4 x 150 mg vials] (&) (inert substance) diluent [4 vials], 1 pack (containered trade product pack) | Is a | Ilaris (4 x 150 mg vials, 4 x inert diluent vials), 1 pack | true | Inferred relationship | Some | ||
| Ilaris (canakinumab 150 mg) powder for injection [4 x 150 mg vials] (&) (inert substance) diluent [4 vials], 1 pack (containered trade product pack) | has TPUU | Ilaris (canakinumab 150 mg) powder for injection, 150 mg vial | true | Inferred relationship | Some | 2 | |
| Ilaris (canakinumab 150 mg) powder for injection [4 x 150 mg vials] (&) (inert substance) diluent [4 vials], 1 pack (containered trade product pack) | has TPUU | Ilaris (inert substance) diluent, vial | true | Inferred relationship | Some | 1 | |
| Ilaris (canakinumab 150 mg) powder for injection [4 x 150 mg vials] (&) (inert substance) diluent [4 vials], 1 pack (containered trade product pack) | has container type | composite pack | false | Inferred relationship | Some | ||
| Ilaris (canakinumab 150 mg) powder for injection [4 x 150 mg vials] (&) (inert substance) diluent [4 vials], 1 pack (containered trade product pack) | has TP | Ilaris | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR